Measuring muscle properties in COPD patients
Official title: Mechanical Properties of Peripheral and Accessory Respiratory Muscles in Chronic Obstructive Pulmonary Disease Patients
Run by Istanbul Medipol University Hospital · NCT06201403 · Data updated 2026-11-12
This study is testing how the muscles used for breathing in people with COPD work compared to healthy individuals to better understand their differences.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | Istanbul Medipol University Hospital Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Status | Recruiting |
| Started | January 20, 2024 |
| Main results expected | January 15, 2026 |
| Study ends | January 15, 2026 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT06201403 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with group C and D COPD who have stable medication regimens and no significant comorbid conditions.
✕Probably not a fit
Patients with other respiratory diseases, recent COPD exacerbations, or those with conditions affecting measurement quality may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the biomechanical properties of accessory and peripheral respiratory muscles in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to healthy individuals. Using the MyotonPro device, the study will measure and analyze muscle characteristics to understand differences in muscle function related to COPD. The research focuses on patients diagnosed with group C and D COPD according to GOLD staging, ensuring they have stable medication regimens and no significant comorbidities. Healthy participants will also be included for comparative analysis.
Why it matters
Potential benefit: If successful, this study could enhance understanding of respiratory muscle function in COPD, potentially leading to improved management strategies for patients.
How similar studies have gone: While the specific approach of measuring muscle properties in COPD patients may be novel, similar studies have explored respiratory muscle function and have shown varying degrees of success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being diagnosed with group C and D COPD according to GOLD staging * Having been using the same medications for the last 4 weeks * No additional comorbid diseases of the orthopedic, neurological or cardiac system Exclusion Criteria: * Presence of another respiratory system disease other than COPD * Patients who have had an acute COPD exacerbation in the last 4 weeks * Patients experiencing COPD exacerbations during the study protocol * Presence of fatty tissue at the measurement points, which may impair the measurement quality. * Have already participated in another clinical trial within the last 30 days that may affect the results of the study. Inclusion Criteria for Healthy Cases * Being over 18 years of age * Not having any diagnosed chronic disease * Not being a smoker
Where it's running
-
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Esra Pehli̇van
- Email: fztesrakambur@yahoo.com
- Phone: 09050585279
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.